İbrahim İLERİ
European Journal of Geriatrics and Gerontology - 2026;8(1):45-49
Objective: The C-reactive protein/albumin ratio (CAR) is used to assess the severity of inflammation. It can provide prognostic information for many diseases. CAR is a more sensitive predictor of systemic inflammatory status than the separate evaluation of these 2 parameters. In this study, we investigated the ability of CAR to predict mortality in non-cancer patients followed in the palliative care service. Materials and Methods: Patients admitted to the palliative service between November 1, 2024, and May 1, 2025 were included. Patients with active rheumatological disease, active infection, cancer, or those transferred to other units during the study were excluded. It was a prospective study involving 200 patients. Results: The median CAR value in the non-survivor group was 4.04 [interquartile range (IQR) 5.05]. This value was 1.89 (2.99) IQR in the survivor group (p <= 0.001). Logistic regression analysis showed that a high CAR value and a diagnosis of cerebrovascular disease (CVD) are risk factors affecting palliative care mortality in non-cancer patients [respectively; odds ratio (OR) = 1.310, p <= 0.001, confidence interval (CI) = 1.121-1.531; OR = 3.359, p = 0.043, CI = 1.042-10.832]. Conclusion: A high CAR value and a CVD diagnosis were risk factors for mortality in non-cancer palliative care patients.
